These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38442915)

  • 1. PDE10A Mutation as an Emerging Cause of Childhood-Onset Hyperkinetic Movement Disorders: A Review of All Published Cases.
    Kalampokini S; Xiromerisiou G; Bargiotas P; Anastasiadou VC; Costeas P; Hadjigeorgiou GM
    Neuropediatrics; 2024 Aug; 55(4):217-223. PubMed ID: 38442915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.
    Mencacci NE; Kamsteeg EJ; Nakashima K; R'Bibo L; Lynch DS; Balint B; Willemsen MA; Adams ME; Wiethoff S; Suzuki K; Davies CH; Ng J; Meyer E; Veneziano L; Giunti P; Hughes D; Raymond FL; Carecchio M; Zorzi G; Nardocci N; Barzaghi C; Garavaglia B; Salpietro V; Hardy J; Pittman AM; Houlden H; Kurian MA; Kimura H; Vissers LE; Wood NW; Bhatia KP
    Am J Hum Genet; 2016 Apr; 98(4):763-71. PubMed ID: 27058447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the genotype-phenotype landscape of PDE10A-associated movement disorders.
    Bohlega S; Abusrair AH; Al-Qahtani Z; Guzmán-Vega FJ; Ramakrishnan R; Aldosari H; Aldakheel A; Al-Qahtani S; Monies D; Arold ST
    Parkinsonism Relat Disord; 2023 Mar; 108():105323. PubMed ID: 36805523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic Mutations in PDE10A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy.
    Diggle CP; Sukoff Rizzo SJ; Popiolek M; Hinttala R; Schülke JP; Kurian MA; Carr IM; Markham AF; Bonthron DT; Watson C; Sharif SM; Reinhart V; James LC; Vanase-Frawley MA; Charych E; Allen M; Harms J; Schmidt CJ; Ng J; Pysden K; Strick C; Vieira P; Mankinen K; Kokkonen H; Kallioinen M; Sormunen R; Rinne JO; Johansson J; Alakurtti K; Huilaja L; Hurskainen T; Tasanen K; Anttila E; Marques TR; Howes O; Politis M; Fahiminiya S; Nguyen KQ; Majewski J; Uusimaa J; Sheridan E; Brandon NJ
    Am J Hum Genet; 2016 Apr; 98(4):735-43. PubMed ID: 27058446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of Phosphodiesterases in Movement Disorders.
    Erro R; Mencacci NE; Bhatia KP
    Mov Disord; 2021 Oct; 36(10):2225-2243. PubMed ID: 34155691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzyme.
    Tejeda GS; Whiteley EL; Deeb TZ; Bürli RW; Moss SJ; Sheridan E; Brandon NJ; Baillie GS
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):677-688. PubMed ID: 31871190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP.
    Handa N; Mizohata E; Kishishita S; Toyama M; Morita S; Uchikubo-Kamo T; Akasaka R; Omori K; Kotera J; Terada T; Shirouzu M; Yokoyama S
    J Biol Chem; 2008 Jul; 283(28):19657-64. PubMed ID: 18477562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE10A mutations help to unwrap the neurobiology of hyperkinetic disorders.
    Whiteley EL; Tejeda GS; Baillie GS; Brandon NJ
    Cell Signal; 2019 Aug; 60():31-38. PubMed ID: 30951862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea.
    Salpietro V; Perez-Dueñas B; Nakashima K; San Antonio-Arce V; Manole A; Efthymiou S; Vandrovcova J; Bettencourt C; Mencacci NE; Klein C; Kelly MP; Davies CH; Kimura H; Macaya A; Houlden H
    Mov Disord; 2018 Mar; 33(3):482-488. PubMed ID: 29392776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human phosphodiesterase PDE10A gene genomic organization and evolutionary relatedness with other PDEs containing GAF domains.
    Fujishige K; Kotera J; Yuasa K; Omori K
    Eur J Biochem; 2000 Oct; 267(19):5943-51. PubMed ID: 10998054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity.
    Matthiesen K; Nielsen J
    Biochem J; 2009 Oct; 423(3):401-9. PubMed ID: 19689430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.
    Soderling SH; Bayuga SJ; Beavo JA
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7071-6. PubMed ID: 10359840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging biology of PDE10A.
    Wilson LS; Brandon NJ
    Curr Pharm Des; 2015; 21(3):378-88. PubMed ID: 25159072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of
    D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; Giampà C; Sorge R; Biagioni S; Fusco FR; Sancesario G
    J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial choreoathetosis due to novel heterozygous mutation in PDE10A.
    Narayanan DL; Deshpande D; Das Bhowmik A; Varma DR; Dalal A
    Am J Med Genet A; 2018 Jan; 176(1):146-150. PubMed ID: 29130591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders.
    Pérez-Dueñas B; Gorman K; Marcé-Grau A; Ortigoza-Escobar JD; Macaya A; Danti FR; Barwick K; Papandreou A; Ng J; Meyer E; Mohammad SS; Smith M; Muntoni F; Munot P; Uusimaa J; Vieira P; Sheridan E; Guerrini R; Cobben J; Yilmaz S; De Grandis E; Dale RC; Pons R; Peall KJ; Leuzzi V; Kurian MA
    Mov Disord; 2022 Nov; 37(11):2197-2209. PubMed ID: 36054588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.
    Niccolini F; Mencacci NE; Yousaf T; Rabiner EA; Salpietro V; Pagano G; Balint B; Efthymiou S; Houlden H; Gunn RN; Wood N; Bhatia KP; Politis M
    Mov Disord; 2018 Dec; 33(12):1961-1965. PubMed ID: 30345538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A).
    Fujishige K; Kotera J; Michibata H; Yuasa K; Takebayashi S; Okumura K; Omori K
    J Biol Chem; 1999 Jun; 274(26):18438-45. PubMed ID: 10373451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research.
    Jankowska A; Świerczek A; Wyska E; Gawalska A; Bucki A; Pawłowski M; Chłoń-Rzepa G
    Curr Drug Targets; 2019; 20(1):122-143. PubMed ID: 30091414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms.
    Hebb AL; Robertson HA; Denovan-Wright EM
    Neuroscience; 2004; 123(4):967-81. PubMed ID: 14751289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.